NLLSS: Predicting Synergistic Drug Combinations Based on Semi-supervised Learning

Synergy evaluation by a pathway–pathway interaction network: a new way to predict drug combination

(2016) Di Chen et al.   Molecular BioSystems

Large-Scale Prediction of Beneficial Drug Combinations Using Drug Efficacy and Target Profiles

(2015) Hiroaki Iwata et al.   Journal of Chemical Information and Modeling

DrugComboRanker: drug combination discovery based on target network analysis

(2014) L. Huang et al.   BIOINFORMATICS

ASDCD: Antifungal Synergistic Drug Combination Database

(2014) Xing Chen et al.   PLoS One

Synergistic and Antagonistic Drug Combinations Depend on Network Topology

(2014) Ning Yin et al.   PLoS One

Systematic prediction of drug combinations based on clinical side-effects

(2014) Hui Huang et al.   Scientific Reports

Novel human lncRNA–disease association inference based on lncRNA expression profiles

(2013) Xing Chen et al.   BIOINFORMATICS

Genetic and Genomic Architecture of the Evolution of Resistance to Antifungal Drug Combinations

(2013) Jessica A. Hill et al.   PLoS Genetics

Prediction of Disease-Related Interactions between MicroRNAs and Environmental Factors Based on a Semi-Supervised Classifier

(2012) Xing Chen et al.   PLoS One

Network target for screening synergistic drug combinations with application to traditional Chinese medicine

(2011) Shao Li et al.   BMC Systems Biology

Chimeras of Candida albicans Cdr1p and Cdr2p reveal features of pleiotropic drug resistance transporter structure and function

(2011) Koichi Tanabe et al.   MOLECULAR MICROBIOLOGY

Prediction of Drug Combinations by Integrating Molecular and Pharmacological Data

(2011) Xing-Ming Zhao et al.   PLoS Computational Biology

Semi-supervised drug-protein interaction prediction from heterogeneous biological spaces

(2010) Zheng Xia et al.   BMC Systems Biology

A Pharmacodynamic Study of Docetaxel in Combination with the P-glycoprotein Antagonist Tariquidar (XR9576) in Patients with Lung, Ovarian, and Cervical Cancer

(2010) R. J. Kelly et al.   CLINICAL CANCER RESEARCH

Statistical Metamodeling for Revealing Synergistic Antimicrobial Interactions

(2010) Chia Hsiang Chen et al.   PLoS One

Biotransformation and in vitro assessment of metabolism-associated drug–drug interaction for CRx-102, a novel combination drug candidate

(2009) Zhi-Yi Zhang et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Chemogenomic profiling predicts antifungal synergies

(2009) Gregor Jansen et al.   Molecular Systems Biology

Synergistic drug combinations tend to improve therapeutically relevant selectivity

(2009) Joseph Lehár et al.   NATURE BIOTECHNOLOGY

Posaconazole: An Oral Triazole with an Extended Spectrum of Activity

(2008) Erik J Rachwalski et al.   ANNALS OF PHARMACOTHERAPY

Posaconazole Combined with Amphotericin B, an Effective Therapy for a Murine Disseminated Infection Caused by Rhizopus oryzae

(2008) M. M. Rodriguez et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

ABC Transporter Cdr1p Contributes More than Cdr2p Does to Fluconazole Efflux in Fluconazole-Resistant Candida albicans Clinical Isolates

(2008) A. R. Holmes et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Stress, Drugs, and Evolution: the Role of Cellular Signaling in Fungal Drug Resistance

(2008) Leah E. Cowen et al.   EUKARYOTIC CELL

High-order combination effects and biological robustness

(2008) Joseph Lehár et al.   Molecular Systems Biology

The evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype

(2008) Leah E. Cowen   NATURE REVIEWS MICROBIOLOGY